- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/21 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Pseudomonadaceae (F)
Patent holdings for IPC class C07K 14/21
Total number of patents in this class: 540
10-year publication summary
|
53
|
43
|
61
|
52
|
51
|
52
|
33
|
33
|
30
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pioneer Hi-Bred International, Inc. | 6486 |
46 |
| Glaxosmithkline Biologicals S.A. | 1634 |
36 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
22 |
| Aridis Pharmaceuticals Inc. | 26 |
10 |
| University of Maryland, Baltimore | 1005 |
10 |
| The Board of Trustees of the University of Illinois | 2682 |
8 |
| The Government of The United States of America AS represented by The Secretary of The Department of Health and Human Services | 176 |
7 |
| Wake Forest University Health Sciences | 717 |
7 |
| President and Fellows of Harvard College | 5942 |
6 |
| Arne Forsgren AB | 6 |
5 |
| National Research Council of Canada | 1547 |
5 |
| Plant Health Care, Inc. | 53 |
5 |
| Spogen Biotech Inc. | 131 |
5 |
| Viventia Bio Inc. | 22 |
5 |
| Applied Molecular Transport Inc. | 18 |
5 |
| Evonik Operations GmbH | 4040 |
5 |
| Corteva Agriscience LLC | 2659 |
5 |
| Evaxion Biotech A/S | 50 |
5 |
| BASF SE | 20758 |
4 |
| E. I. du Pont de Nemours and Company | 4127 |
4 |
| Other owners | 335 |